Gastroesophageal reflux disease, commonly known as GERD, is a chronic condition that affects millions of people worldwide. It occurs when acid from the stomach leaks up into the esophagus, causing heartburn and damage to the esophageal lining over time. While lifestyle changes and medications can help manage symptoms, more invasive treatment options are available in severe or refractory cases. This article explores some of the emerging medical devices used to treat GERD.
For patients whose symptoms are not adequately controlled with lifestyle changes and medications, antireflux surgery may offer relief. One of the most common procedures is laparoscopic Nissen fundoplication, which involves wrapping the top of the stomach around the lower esophagus to form a tight “valve.” This helps prevent stomach acid from refluxing into the esophagus. While very effective at controlling GERD, the surgery is invasive and not reversible if symptoms return later. However, minimally invasive surgical devices have been developed to provide alternatives.
Endoscopic treatments involve procedures performed by a gastroenterologist using an endoscope. This allows treatments to be delivered internally through the mouth without requiring open abdominal surgery. One such treatment is endoscopic radiofrequency therapy. During this procedure, radiofrequency energy is delivered through an endoscope to the lower esophageal sphincter. This triggers a healing response which strengthens the muscles and increases pressure, preventing acid reflux. While short-term outcomes are promising, longer term studies are still needed.
Another nonsurgical option is endoscopic implantation of magnetic beads. This involves injecting magnetic beads around the lower esophageal sphincter which pull together and reinforce the valve using an external controlled magnetic field. Initial studies found this treatment significantly reduced symptoms and use of antireflux medications in over 70% of patients at 6 months. Larger trials are underway, but it shows promise as a noninvasive, reversible option for managing GERD.
The Stretta procedure delivers radiofrequency energy to the lower esophageal sphincter and cardia through an endoscope. This triggers scarring and thickening of tissue that functions to improve barrier pressure at the LES. The treatment takes about an hour to complete and can be performed in an outpatient setting under moderate sedation. Studies show the Stretta procedure significantly reduces medication use and heartburn symptoms for up to 10 years in properly selected patients. While not as effective as surgery, it provides an alternative with fewer side effects than open or laparoscopic procedures.
Transoral Incisionless Fundoplication
Rather than traditional surgical fundoplication, a newer approach called transoral incisionless fundoplication (TIF) is gaining recognition. During TIF, a specially designed device is passed through the mouth and esophagus under endoscopic guidance. It then plicates or folds the fundus of the stomach around the lower esophageal sphincter without requiring abdominal incisions. Several full-thickness stitches are placed using a suturing device and fasteners to create a tight antireflux valve. Early studies found TIF significantly improved GERD symptoms and medication use in 70-80% of patients at 2 years with minimal side effects. Larger, long-term trials continue to evaluate outcomes and durability of effect.
A commonly used TIF system is the EsophyX device made by EndoGastric Solutions. It features a flexible endoscope with an attached dissecting balloon and suturing capsule. Under endoscopic and fluoroscopic guidance, the balloon is inflated in the stomach to dissect a flap of tissue. The capsule then places full-thickness, multi-point plications to fold the flap around the LES. The procedure takes about an hour to complete. Results from early trials found 87% of patients had resolution or improvement of regurgitation and heartburn symptoms at 3 years. Complications were mild and low. Updated techniques continue refining safety and outcomes.
LINX Reflux Management System
For patients who prefer alternatives to fundoplication surgery, the LINX Reflux Management System is an emerging option. It involves implanting a small magnetic device around the lower esophageal sphincter during a minimally invasive laparoscopic procedure. The device consists of interlinked titanium beads with magnetic cores that reinforce the LES barrier. Studies found LINX significantly improved Gastroesophageal Reflux Disease Treatment Devices symptoms in over 75% of patients at 5 years with a low adverse event rate. While further assessment is still needed, it provides a reversible option short of full fundoplication for carefully selected GERD patients.
Development of endoluminal treatments continues as researchers work to refine existing approaches and develop new technologies. Areas of focus include improving procedural ease and efficacy of magnetic sphincter augmentation devices. Novel fundoplication systems aim to standardize technique while minimizing pain and recovery times. Bioabsorbable surgical fasteners may one day replace permanent implants. Device delivery methods are integrating robotic and robotic endoscopic technologies for enhanced visualization and control. With ongoing innovation, new generations of less invasive GERD therapies promise enhanced management options for suitable patients suffering from this widespread condition.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it